About Henry Schein, Inc.
https://www.henryschein.comHenry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
CEO
Stanley M. Bergman CPA
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2019-02-08 | Forward | 51:40 |
| 2017-09-15 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 355
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Barrington Research
Outperform
Evercore ISI Group
Outperform
JP Morgan
Overweight
Piper Sandler
Overweight
Wells Fargo
Equal Weight
UBS
Neutral
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
KOHLBERG KRAVIS ROBERTS & CO. L.P.
Shares:15.65M
Value:$1.19B
VANGUARD GROUP INC
Shares:12M
Value:$915.18M
BLACKROCK INC.
Shares:9.54M
Value:$727.36M
Summary
Showing Top 3 of 794
About Henry Schein, Inc.
https://www.henryschein.comHenry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.34B ▲ | $752M ▼ | $101M ▲ | 3.02% ▲ | $0.84 ▲ | $255M ▲ |
| Q2-2025 | $3.24B ▲ | $777M ▲ | $86M ▼ | 2.65% ▼ | $0.71 ▼ | $235M ▼ |
| Q1-2025 | $3.17B ▼ | $736M ▼ | $110M ▲ | 3.47% ▲ | $0.89 ▲ | $253M ▲ |
| Q4-2024 | $3.19B ▲ | $738M ▲ | $94M ▼ | 2.95% ▼ | $0.75 ▼ | $237M ▲ |
| Q3-2024 | $3.17B | $724M | $99M | 3.12% | $0.79 | $236M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $136M ▼ | $11.1B ▲ | $6.2B ▲ | $3.36B ▼ |
| Q2-2025 | $145M ▲ | $10.91B ▲ | $6.01B ▲ | $3.44B ▲ |
| Q1-2025 | $127M ▲ | $10.48B ▲ | $5.76B ▲ | $3.31B ▼ |
| Q4-2024 | $122M ▼ | $10.22B ▼ | $5.38B ▼ | $3.39B ▼ |
| Q3-2024 | $126M | $10.61B | $5.63B | $3.5B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $101M ▲ | $174M ▲ | $-58M ▲ | $-125M ▼ | $-9M ▼ | $141M ▲ |
| Q2-2025 | $86M ▼ | $120M ▲ | $-102M ▼ | $60M ▼ | $18M ▲ | $88M ▲ |
| Q1-2025 | $113M ▲ | $37M ▼ | $-99M ▼ | $89M ▲ | $5M ▲ | $-6M ▼ |
| Q4-2024 | $96M ▼ | $204M ▲ | $-58M ▲ | $-204M ▼ | $-4M ▲ | $159M ▲ |
| Q3-2024 | $99M | $151M | $-135M | $3M | $-12M | $117M |
Revenue by Products
| Product | Q3-2023 | Q1-2024 | Q2-2024 | Q3-2024 |
|---|---|---|---|---|
 Healthcare Distribution | $2.95Bn ▲ | $2.96Bn ▲ | $2.92Bn ▼ | $2.95Bn ▲ |
 Technology | $210.00M ▲ | $220.00M ▲ | $210.00M ▼ | $220.00M ▲ |
Revenue by Geography
| Region | Q3-2023 | Q1-2024 | Q3-2024 | Q2-2024 |
|---|---|---|---|---|
 International | $800.00M ▲ | $870.00M ▲ | $820.00M ▼ | $850.00M ▲ |
 North America | $2.36Bn ▲ | $2.31Bn ▼ | $2.35Bn ▲ | $2.29Bn ▼ |
CEO
Stanley M. Bergman CPA
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2019-02-08 | Forward | 51:40 |
| 2017-09-15 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 355
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Barrington Research
Outperform
Evercore ISI Group
Outperform
JP Morgan
Overweight
Piper Sandler
Overweight
Wells Fargo
Equal Weight
UBS
Neutral
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
KOHLBERG KRAVIS ROBERTS & CO. L.P.
Shares:15.65M
Value:$1.19B
VANGUARD GROUP INC
Shares:12M
Value:$915.18M
BLACKROCK INC.
Shares:9.54M
Value:$727.36M
Summary
Showing Top 3 of 794